Work

Molecular age of Barrett’s esophagus indicates onset often occurs decades before diagnosis

Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background Timely identification of Barrett’s esophagus (BE) is crucial for early esophageal adenocarcinoma (EAC) detection. Screening is recommended from age 50 in individuals with additional risk factors, but biological BE onset age remains unknown. Objective Estimate biological BE onset age and duration before clinical diagnosis (dwell time). Design We applied a BE epigenetic clock to 61 samples from 41 patients in a population-representative Northern Ireland cohort and 164 samples from 140 patients in an independent UK cohort. BE dwell times were compared between patients with concurrent dysplasia/EAC and age- and sex-matched non-dysplastic BE controls in these cross-sectional studies. In a longitudinal cohort, pre-progression biopsies from 31 future high-grade dysplasia (HGD)/EAC progressors were compared with 35 non-progressors. Results Median estimated BE onset ages in the cross-sectional cohorts were 29.5 (IQR=22.5-45.8) and 29.3 (IQR=20.4-39.0) years, respectively. These estimates were further supported by independent epidemiologic modeling of age-specific BE prevalence data from more than 70,000 BE cases. Estimated dwell times were longer in patients with concurrent dysplasia (median difference 14.3 years; p=0.0042) or EAC (12.5 years; p=0.0002) than matched non-dysplastic BE controls. Dwell time exceeding 19.8 years was associated with higher odds of HGD/EAC progression (OR=12.1, 95% CI 3.7-47.5; p=9.96 × 10⁻⁵). Conclusion BE may arise decades before diagnosis. Although these findings do not justify lowering screening age, they suggest one-time screening from age 50 years may detect existing high-risk BE. Further modeling is warranted to evaluate implications for population-based screening, alongside prospective validation of epigenetic tissue age for progression risk stratification. Key Messages What is already known on this topic Increasing patient age is a major clinical risk factor for both esophageal adenocarcinoma (EAC) and its precursor lesion, Barrett’s esophagus (BE), but the biological age or dwell time of BE before diagnosis cannot be directly measured clinically, limiting our understanding of BE onset timing and past disease evolution. What this study adds Using a methylation-based molecular clock model applied to 294 tissue samples, we estimated that the median age of onset of BE is approximately 30 years old in 3 independent UK cohorts with BE. We found substantial interpatient variability in estimated BE onset age, significantly older BE tissue age in patients with adjacent EAC or dysplasia, and 12-fold higher odds of HGD/EAC progression for patients with older BE tissue age in a prospectively followed cohort. How this study might affect research, practice or policy These findings suggest that BE may arise decades before clinical diagnosis, providing a prolonged window for EAC prevention and supporting further investigation of one-time screening from age 50 to identify existing high-risk BE, rather than broadly lowering screening ages. Molecular estimates of BE tissue age may improve computational models of BE natural history and inform future biomarkers for neoplastic progression risk stratification, warranting further modeling and prospective validation to assess their potential utility in personalized screening and surveillance strategies.
Source: medRxiv
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: green
OpenAlex ID: W7235686342
Cites: 49
Cited by:
Related to: 10